share_log

Prescient Therapeutics Ltd: PTX-100 Ph1b results show excellent safety & efficacy in TCL

Dec 11, 2023 05:32
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.